Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer

NCT00374140 is registered in ClinicalTrials.gov with Ahmad Tarhini as lead sponsor.

NCT NCT00374140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00374140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Lead sponsor
Ahmad Tarhini
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
June 30, 2012
Enrollment
40 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer